NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1032 coverBiobehavioral Stress Response: Protective and Damaging Effects Volume 1032 published December 2004
Ann. N.Y. Acad. Sci. 1032: 191–194 (2004). doi: 10.1196/annals.1314.018
Copyright © 2004 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by WOLKOWITZ, O. M.
Articles by CANICK, J.
Search for Related Content
PubMed
PubMed Citation
Articles by WOLKOWITZ, O. M.
Articles by CANICK, J.
The "Steroid Dementia Syndrome": An Unrecognized Complication of Glucocorticoid Treatment

OWEN M. WOLKOWITZ, SONIA J. LUPIEN, ERIN BIGLER, R BRONSON LEVIN AND JONATHAN CANICK

University of California, San Francisco, School of Medicine, San Francisco, California 94143-0894,USA

Address for correspondence: Owen M. Wolkowitz, MD, UCSF School of Medicine, 401 Parnassus Ave., Box F-0984, San Francisco, CA 94143-0984, USA. Voice: 415-476-7433; fax: 415-502-2661. owenw{at}itsa.ucsf.edu

Glucocorticoid treatment is frequently associated with transiently impaired attention, concentration, and memory. In rare cases, cognitive changes may be prominent and may persist for substantial periods of time after steroid discontinuation. This largely unrecognized complication has been termed the "steroid dementia syndrome" and may reflect steroid neuroendangerment or neurotoxicity. Several clinical cases of this syndrome, with shared phenomenological and neuropsychological features, are presented here.

Key Words: steroid • dementia • glucocorticoid • prednisone • memory • hippocampus




This article has been cited by other articles:


Home page
Ann Rheum DisHome page
S Appenzeller, A D Carnevalle, L M Li, L T L Costallat, and F Cendes
Hippocampal atrophy in systemic lupus erythematosus
Ann Rheum Dis, December 1, 2006; 65(12): 1585 - 1589.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. I. Prodan, M. Monnot, E. D. Ross, and A. E. Coleman
Reversible dementia with parkinsonian features associated with budesonide use.
Neurology, August 22, 2006; 67(4): 723 - 723.
[Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
J Dvorak, N Feddermann, and K Grimm
Glucocorticosteroids in football: use and misuse
Br. J. Sports Med., July 1, 2006; 40(suppl_1): i48 - i54.
[Abstract] [Full Text] [PDF]



footerLeft footerRight